Literature DB >> 28476384

Risk Factors Associated With Nonunion After Elective Foot and Ankle Reconstruction: A Case-Control Study.

Kyle R Moore1, Michael A Howell2, Karl R Saltrick3, Alan R Catanzariti4.   

Abstract

Postoperative nonunion is not uncommon in the lower extremity, and significant morbidity can be associated with nonunion of the foot and ankle after surgical reconstruction. For the purposes of the present study, we retrospectively reviewed and compared a cohort of patients who had undergone elective foot and ankle reconstruction to better assess the modifiable risk factors associated with postoperative nonunion. We hypothesized that the presence of endocrine and metabolic abnormalities are often associated with nonunion after foot and ankle surgical reconstruction. We formulated a matched case-control study that included 29 patients with nonunion and a control group of 29 patients with successful fusion to assess the prevalence of certain modifiable risk factors known to have an association with nonunion after foot and ankle arthrodesis. The modifiable risk factors assessed included body mass index, tobacco use, diabetes mellitus, vitamin D abnormality, thyroid dysfunction, and parathyroid disease. A statistically significant (p < .05) difference was found between the 2 groups for endocrine and metabolic disease diagnoses in the medical records of the 58 patients identified. Thus, 76% versus 26% (p < .05) of patients experienced nonunion in the endocrine disease group versus the nonendocrine disease group, respectively. Patients with vitamin D deficiency or insufficiency were 8.1 times more likely to experience nonunion (95% confidence interval 1.996 to 32.787). No statistically significant differences were found between the groups in terms of age, sex, tobacco use, body mass index, or procedure selection (p = .56, p = .43, p = .81, p = .28, and p = 1.0, respectively). A greater prevalence of endocrine abnormalities, in particular, vitamin D deficiency and insufficiency, was associated with nonunion after elective foot and ankle reconstruction. Patients with such abnormalities appear to have a greater risk of developing nonunion after arthrodesis procedures.
Copyright © 2017 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ankle; arthrodesis; foot; fusion; nonunion; risk factors

Mesh:

Year:  2017        PMID: 28476384     DOI: 10.1053/j.jfas.2017.01.011

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  6 in total

1.  Current concepts in the management of ankle arthritis.

Authors:  V Adukia; J Mangwani; R Issac; S Hussain; L Parker
Journal:  J Clin Orthop Trauma       Date:  2020-04-08

2.  Factors Associated With Nonunion and Infection Following Ankle Arthrodesis Using a Large Claims Database: Who Has Elevated Risk?

Authors:  Liam H Wong; Bopha Chrea; James E Meeker; Jung U Yoo; Lara C Atwater
Journal:  Foot Ankle Orthop       Date:  2022-05-29

3.  1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites.

Authors:  Samiksha Wasnik; Charles H Rundle; David J Baylink; Mohammad Safaie Yazdi; Edmundo E Carreon; Yi Xu; Xuezhong Qin; Kin-Hing William Lau; Xiaolei Tang
Journal:  JCI Insight       Date:  2018-09-06

Review 4.  Triple Arthrodesis for Adult-Acquired Flatfoot Deformity.

Authors:  Maj Uma E Erard; Maj Andrew J Sheean; Bruce J Sangeorzan
Journal:  Foot Ankle Orthop       Date:  2019-08-19

5.  Prospective, Multicenter, Clinical and Radiographic Evaluation of a Biointegrative, Fiber-Reinforced Implant for Proximal Interphalangeal Joint Arthrodesis.

Authors:  Luke D Cicchinelli; Jurij Štalc; Martinus Richter; Stuart Miller
Journal:  Foot Ankle Orthop       Date:  2020-11-27

6.  Distal metatarsal osteotomy and dorsal neutralization plate in the treatment of hallux valgus.

Authors:  Tahsin Olgun Bayraktar; Ali Yüce; Mustafa Yerli; Ali Cagri Tekin; Hakan Gürbüz
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.